The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

@article{Bartalena2016The2E,
  title={The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.},
  author={Luigi Bartalena and Lelio Baldeschi and Kostas Boboridis and Anja Katrin Eckstein and G J Kahaly and Claudio Marcocci and P Perros and Mario Salvi and Wilmar M Wiersinga},
  journal={European thyroid journal},
  year={2016},
  volume={5 1},
  pages={9-26}
}
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient's quality of life. Local measures (artificial tears, ointments and dark glasses) and control of risk factors for progression (smoking and… CONTINUE READING